The global Biotechnology industry is witnessing remarkable expansion as innovations in genomics, synthetic biology, regenerative medicine, and artificial intelligence reshape healthcare and industrial applications worldwide. Increasing investments in research and development, rising demand for personalized medicine, and rapid advancements in gene-editing technologies are accelerating market...

Biomarker Discovery Technologies: Driving Precision Medicine Through Multi-Omics and Gene Expression Innovation Biomarker discovery technologies are at the forefront of modern biomedical research, enabling scientists to identify, validate, and translate biological markers that reflect disease states, therapeutic responses, and physiological processes. These technologies are essential for...

According to the latest report published by Data Bridge Market Research, the Diagnostic Imaging Equipment Market  CAGR Value The global diagnostic imaging equipment market size was valued at USD 53.60 billion in 2024 and is expected to reach USD 78.59 billion by 2032, at a CAGR of 4.90% during the forecast period All the statistical data including facts and figures that are...

According to a new report from Intel Market Research, the North America Intelligent Biotech Healthcare market was valued at USD 1.38 billion in 2025 and is projected to reach USD 3.16 billion by 2034, exhibiting a robust CAGR of 7.2 % during the forecast period (2026–2034). This growth is propelled by the convergence of artificial‑intelligence (AI) breakthroughs, escalating demand for...

According to a new report from Intel Market Research, the global Brigatinib API market was valued at USD 42.5 million in 2025 and is projected to reach USD 89.7 million by 2034, growing at a robust CAGR of 8.1% during the forecast period (2026–2034). This growth is propelled by the increasing global incidence of non-small cell lung cancer, particularly ALK-positive cases among...

The global Epidermal Growth Factor Receptor (EGFR) inhibitor industry is witnessing substantial momentum due to the increasing prevalence of cancer, growing adoption of targeted therapies, and advancements in precision medicine. The Epidermal Growth Factor Receptor Inhibitor Market size is expected to reach US$ 32.14 Billion by 2034 from US$ 15.92 Billion in 2025. The market is estimated to...

According to a new report from Intel Market Research, the global Selpercatinib Capsules market was valued at USD 420 million in 2025 and is projected to reach USD 820 million by 2034, growing at a CAGR of 7.8% during the forecast period (2026–2034). This growth is propelled by the increasing prevalence of RET-altered cancers, growing adoption of biomarker-driven therapies, and...

According to a new report from Intel Market Research, the global TKIs for Breast Cancer market was valued at USD 1.82 billion in 2025 and is projected to reach USD 3.74 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2025–2034). This growth is propelled by the rising global incidence of breast cancer, growing adoption of precision oncology, and increasing regulatory...

The United States is a key market for liquid biopsy technologies, supported by strong investments in cancer research, widespread adoption of precision medicine, and advanced molecular diagnostic capabilities. The growing focus on early cancer detection, personalized treatment strategies, and non-invasive diagnostic methods continues to drive demand for liquid biopsy solutions across healthcare...

The United States holds a significant position in the smart biopsy devices market, supported by advanced healthcare infrastructure, strong adoption of precision diagnostic technologies, and increasing emphasis on early cancer detection. Growing investments in medical imaging, minimally invasive procedures, and personalized medicine continue to drive the demand for innovative biopsy solutions...